Tevogen Bio Holdings Inc.
15 Independence Boulevard, Suite #410
Warren, New Jersey 07059
August 1, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
| Re: | Tevogen Bio Holdings Inc. | |
| Registration Statement on Form S-1 | ||
| Filed June 21, 2024 | ||
| File No. 333-280414 | ||
| Request for Acceleration of Effectiveness |
To the addressee above:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tevogen Bio Holdings Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on August 2, 2024, or as soon thereafter as possible.
Please feel free to direct any questions or comments concerning this request to Nick Hoover of Hogan Lovells US LLP at (410) 659-2790, and once the Registration Statement has been declared effective, please notify Mr. Hoover by calling him at the same phone number.
| Sincerely, | ||
| Tevogen Bio Holdings Inc. | ||
| /s/ Ryan Saadi | ||
| By: | Ryan Saadi | |
| Title: | Chief Executive Officer and Chairperson of the Board of Directors | |